Cosmic Peptides research library

Residual solvents in peptides: what headspace GC measures and what the ICH limits mean

Which organic solvents a synthetic peptide passes through, how headspace gas chromatography measures what is left, what the ICH Q3C classes and ppm limits mean for a peptide, a worked example, and what the test cannot show.

Part 14 of 25 · Methods and analytics

Last reviewed · Editorial policy

A synthetic peptide passes through several organic solvents before it reaches a vial, and some of each can stay behind in the dried powder. A certificate that reports residual solvents is answering a narrow question: which of those solvents is still present, and how much, in parts per million.

The question matters because the HPLC purity figure cannot answer it. Most solvents absorb little or no ultraviolet light at 214 nm and elute in the solvent front, so a sample can be 99 percent pure by HPLC and still carry solvent from synthesis or purification. Residual solvents are measured by a different instrument, gas chromatography, and judged against a different standard, the International Council for Harmonisation's guideline ICH Q3C.

Federal compounding policy has made the test topical. The Department of Health and Human Services' October 2026 conditions for compounding six peptides, as counsel who have read the document describe them, require a certificate of analysis covering residual solvents alongside identity, purity and impurities. This article explains where residual solvents in peptides come from, how they are measured, what the ICH classes and limits mean, and what the test cannot show.

Where residual solvents in a peptide come from

Every stage of peptide manufacture uses solvent. Solid-phase synthesis builds the chain on a resin bathed in polar aprotic solvents; N,N-dimethylformamide (DMF) and N-methyl-2-pyrrolidone (NMP) are, in the words of a 2026 review, widely employed in peptide and organic synthesis. A cleavage mixture of about 95 percent trifluoroacetic acid releases the finished chain from the resin, and the crude peptide is precipitated in cold ether. Reversed-phase HPLC then purifies it in mixtures of water and acetonitrile with a little trifluoroacetic acid, and the pooled fractions are freeze-dried. How peptides are made sets out each step.

Freeze-drying removes most of the volatile material, but not always all of it. What remains depends on the last solvents the peptide touched and on how thoroughly it was dried, which is why the guideline asks for testing of solvents that are used or produced in the manufacture or purification rather than a fixed list.

How headspace gas chromatography measures peptide solvents

Residual solvents are volatile, so they are measured in the gas phase. In the pharmacopoeial procedure, a weighed portion of the sample is dissolved in a diluent in a sealed vial: water for a water-soluble sample, DMF or a similar solvent for one that is not. The vial is heated until the volatile solvents distribute between the liquid and the gas above it. A portion of that gas, the headspace, is drawn off and introduced into a gas chromatograph, which separates the solvents on a capillary column and detects them, most often with a flame-ionization detector.

Each solvent elutes at a characteristic retention time, and its amount is calculated against a reference standard of the same solvent run under the same conditions. Because only the gas enters the instrument, the peptide itself never reaches the column. ICH Q3C says residual solvents are typically determined using chromatographic techniques such as gas chromatography, and that pharmacopoeial procedures should be used where feasible. Both the United States Pharmacopeia and the European Pharmacopoeia publish such procedures.

The guideline allows one shortcut. If only Class 3 solvents are present, a non-specific method such as loss on drying may be used. Loss on drying measures all the mass a sample loses when heated, water included, so it can show that the total is small but cannot say which solvent is present.

The ICH Q3C classes and limits for peptide solvents

ICH Q3C sorts solvents into three classes by toxicity and gives each a limit. Class 1 solvents, such as benzene, are to be avoided. Class 2 solvents are to be limited, each with its own permitted daily exposure and a concentration limit in parts per million. Class 3 solvents have low toxic potential; up to 0.5 percent, or 5,000 ppm, is acceptable without justification. A fourth table lists solvents for which no adequate toxicological data were found, and for those the guideline asks manufacturers to justify the residual level.

Solvents used in peptide manufacture: ICH Q3C (R8) class and concentration limit
SolventWhere it is usedICH Q3C class and limit
AcetonitrileHPLC purificationClass 2, 410 ppm
N,N-Dimethyl­formamide (DMF)Solid-phase synthesisClass 2, 880 ppm
N-Methyl-2-pyrrolidone (NMP)Solid-phase synthesisClass 2, 530 ppm
EtherPrecipitation of the crude peptideClass 3 (diethyl ether and tert-butyl methyl ether), 5,000 ppm
Trifluoroacetic acidCleavage and HPLC purificationNo class or limit; the manufacturer justifies its level

The Class 2 limits are calculated, not chosen. Each is the solvent's permitted daily exposure converted to a concentration on the assumption, in the guideline's words, of a product mass of 10 g administered daily. Acetonitrile's permitted daily exposure of 4.1 mg becomes 410 ppm. The guideline calls this Option 1 and says its limits are acceptable for all substances, excipients, or products, which is why certificates quote them.

The guideline's scope is pharmaceuticals. It says it does not apply to potential new drug substances, excipients, or drug products used during the clinical research stages of development. For a peptide sold as a laboratory reagent, no limit is binding. The ICH classes are still the common yardstick, and a certificate that cites them is using the same scale a pharmaceutical laboratory would.

A worked example: what 410 ppm means in a peptide vial

Take a vial containing 10 mg of lyophilized peptide powder whose certificate reports acetonitrile at 410 ppm, exactly the Class 2 limit. Parts per million are by mass, so 410 ppm is 410 micrograms per gram. In 10 mg of powder, that is 10 × 410 / 1,000,000 grams, or 0.0041 mg: 4.1 micrograms of acetonitrile.

Now take a Class 3 solvent at its 0.5 percent level. In the same 10 mg, 0.5 percent is 0.05 mg, or 50 micrograms. Both figures are small next to the other non-peptide content of a freeze-dried powder: water, which Karl Fischer titration commonly finds at a few percent, is hundreds of micrograms in a 10 mg vial. Residual solvents at or below their ICH limits barely move the net peptide content. Their significance is as a measure of how well the material was dried and purified, not as a large share of the weight.

The arithmetic runs the other way when a figure is high. A certificate reporting 2 percent of an ether, four times the Class 3 level, describes 200 micrograms in that 10 mg vial and a drying step that was not finished.

Trifluoroacetic acid: a solvent and a counter-ion in peptides

Trifluoroacetic acid needs a separate explanation. ICH Q3C lists it among the solvents with no adequate toxicological data, so it has no class limit. In a peptide it also appears in a second form: as trifluoroacetate, the counter-ion bound to the peptide's basic groups after purification. Bound trifluoroacetate is not volatile and is not measured by headspace GC. It is measured as a counter-ion, by ion chromatography or by 19F NMR, and reported with the salt form. Peptide salt forms explains why the counter-ion is part of a peptide's identity.

What a residual solvent test cannot show

  • Solvents it did not look for. Headspace GC finds the solvents in its reference standard. A solvent outside the method's list is not reported, which is why the guideline ties testing to the solvents actually used in the process.
  • Non-volatile residues. Salts, bound counter-ions, scavengers that do not reach the gas phase and resin fragments are invisible to a headspace method. What HPLC does not see covers the rest of a vial's non-peptide content.
  • The peptide. Residual solvent results say nothing about identity, purity or content. They are one line of a certificate, read with the others. Reading a certificate of analysis sets out the whole document.
  • A different lot. Drying varies between batches. A residual solvent result describes the lot that was tested.

Frequently asked questions

What are residual solvents in peptides?
Traces of the organic solvents used to synthesize and purify a peptide, such as acetonitrile, DMF or ether, that remain in the dried powder. They are reported in parts per million and measured by gas chromatography.
How are residual solvents measured?
By headspace gas chromatography. The sample is dissolved in a sealed, heated vial, and the gas above the solution, carrying the volatile solvents, is introduced into a gas chromatograph. Each solvent is identified by retention time and quantified against a standard.
What is the ICH limit for acetonitrile in a peptide?
ICH Q3C (R8) places acetonitrile in Class 2 with a permitted daily exposure of 4.1 mg, giving a concentration limit of 410 ppm under its Option 1. The guideline applies to pharmaceuticals; for laboratory reagents it is a reference point, not a requirement.
Is trifluoroacetic acid a residual solvent?
Partly. Free trifluoroacetic acid is a volatile solvent, which ICH Q3C lists among those with no adequate toxicological data. Trifluoroacetate bound to the peptide is a counter-ion, measured by ion chromatography or 19F NMR rather than by headspace GC.
Does HPLC purity include residual solvents?
No. Most solvents absorb little light at 214 nm and elute in the solvent front, so they are outside the purity calculation. A separate gas chromatographic test is needed.

Sources & Further Reading

  1. International Council for Harmonisation. ICH Q3C (R8): Impurities: Guideline for Residual Solvents. Step 4, April 22, 2021. Sections 2 (scope), 3.1, 3.3, 3.4, 3.5 and 4; Tables 2, 3 and 4.
  2. Grodowska K, Parczewski A. Analytical methods for residual solvents determination in pharmaceutical products. Acta Poloniae Pharmaceutica 2010;67(1):13–26. PMID 20210075.
  3. Grodowska K, Parczewski A. Organic solvents in the pharmaceutical industry. Acta Poloniae Pharmaceutica 2010;67(1):3–12. PMID 20210074.
  4. Scognamiglio PL, Magli E, Caliendo G, Perissutti E, et al. Once Upon a Time Without DMF: Greener Paths in Peptide and Organic Synthesis. Molecules 2026;31(3):536.
  5. Department of Health and Human Services. Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances; notice of availability. 91 FR 68526, October 30, 2026.

See also

Cite this page

Text

Cosmic Peptides. (2026, November 15). Residual solvents in peptides: what headspace GC measures and what the ICH limits mean. Cosmic Peptides Research Library. Retrieved November 16, 2026, from https://cosmicpeptides.com/research/methods/residual-solvents-in-peptides

BibTeX

@misc{cosmicpeptides_research_methods_residual_solvents_in_peptides,
  author       = {{Cosmic Peptides}},
  title        = {Residual solvents in peptides: what headspace GC measures and what the ICH limits mean},
  howpublished = {Cosmic Peptides Research Library},
  year         = {2026},
  month        = nov,
  url          = {https://cosmicpeptides.com/research/methods/residual-solvents-in-peptides},
  urldate      = {2026-11-16},
  note         = {Last reviewed 2026-11-15}
}

RIS

TY  - ELEC
AU  - Cosmic Peptides
TI  - Residual solvents in peptides: what headspace GC measures and what the ICH limits mean
T2  - Cosmic Peptides Research Library
PB  - Cosmic Peptides
PY  - 2026
DA  - 2026/11/15
UR  - https://cosmicpeptides.com/research/methods/residual-solvents-in-peptides
Y2  - 2026/11/16
LA  - en
ER  - 

Cite the date the page was last reviewed, November 15, 2026, as its version. Reference managers such as Zotero can save this page directly.

Changes to this page

  1. Published Residual solvents in peptides: what headspace GC measures and what the ICH limits mean

    Methods explainer: where residual solvents in a synthetic peptide come from, how headspace gas chromatography measures them, the ICH Q3C (R8) classes and concentration limits for the solvents used in peptide manufacture, a worked example in micrograms per vial, trifluoroacetic acid as solvent and counter-ion, and what the test cannot show. Glossary term added.

Changes of substance are listed here; wording changes are not. Every correction is also on the corrections log.

For in vitro laboratory research only. Not for human or veterinary use. This library describes chemistry, analytical methods and published laboratory research; it gives no guidance on use in people or animals.